Most of these studies analyzed patients treated with conventional chemotherapy (CHOP) [9–12], but there is only one study that analyzed the prognostic significance of survivin in patients with DLBCL treated with immunochemotherapy (ICH) [13]. Here, BIRC5 is linked to diffuse large B-cell lymphoma.